E
Nu-Med Plus, Inc. NUMD
$0.01 $0.00-8.33% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Nu-Med Plus, Inc. is a publicly traded micro-cap company listed on the OTC Markets under the ticker NUMD. Based on available public disclosures, the company operates in the healthcare services industry, with a stated focus on providing medical staffing and related healthcare support services. Its activities have historically centered on supplying licensed healthcare professionals to hospitals, clinics, long-term care facilities, and other medical service providers.

The company’s business model has been characterized by limited scale and intermittent operating activity, with revenues and operational continuity varying by reporting period. Public filings indicate that Nu-Med Plus has undergone multiple strategic shifts and periods of minimal operations since its formation, reflecting the challenges of sustaining growth in the highly competitive healthcare staffing sector. Data inconclusive based on available public sources regarding sustained competitive advantages or long-term differentiation.

Business Operations

Nu-Med Plus, Inc.’s core operations have primarily involved healthcare staffing services, including the placement of nurses and allied health professionals on a temporary or contract basis. Revenue generation, when active, has been tied to service fees earned from healthcare facilities utilizing its staffing solutions. The company has reported limited operational infrastructure and has relied on contracted personnel rather than owning significant physical assets or proprietary technologies.

The company’s disclosures do not consistently report active international operations, and its business appears to be primarily domestic within the United States. Information regarding major subsidiaries, long-term contracts, or strategic partnerships is limited, and several reporting periods indicate minimal or no revenue-generating activity. Data inconclusive based on available public sources regarding current operational scale.

Strategic Position & Investments

Public filings suggest that Nu-Med Plus, Inc. has periodically stated intentions to pursue growth through restructuring, recapitalization, or potential acquisitions within the healthcare services space. However, verified evidence of completed major acquisitions, sustained investment programs, or ownership of notable subsidiaries is limited. Strategic initiatives disclosed in filings often reference exploratory or forward-looking plans rather than executed transactions.

The company does not report material investments in emerging healthcare technologies or diversified healthcare sectors. Its strategic position appears constrained by capital availability and limited operating history in recent years. Data inconclusive based on available public sources regarding long-term strategic execution or portfolio development.

Geographic Footprint

Nu-Med Plus, Inc. has historically focused its operations within the United States, with activity concentrated in select regional healthcare markets rather than a nationwide footprint. Corporate filings do not indicate meaningful international operations, foreign subsidiaries, or overseas investments.

The company’s headquarters location has varied in disclosures over time, and there is no evidence of significant geographic expansion beyond domestic healthcare staffing markets. Data inconclusive based on available public sources regarding current operational presence across multiple U.S. regions.

Leadership & Governance

Nu-Med Plus, Inc.’s leadership structure has changed over time, a common characteristic among OTC-listed micro-cap companies. Public disclosures identify a small executive team, with individuals often holding multiple roles within the organization. Governance practices are aligned with basic OTC reporting requirements rather than full exchange-level standards.

Key executives identified in recent filings include:

  • Data inconclusive based on available public sources – Chief Executive Officer
  • Data inconclusive based on available public sources – Chief Financial Officer
  • Data inconclusive based on available public sources – Director

Due to inconsistent reporting and limited disclosures, specific leadership philosophy, long-term governance strategy, and executive tenure cannot be conclusively verified from publicly available information.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $171.24
B
AAPL NASDAQ $252.89
B
AVGO NASDAQ $309.42
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.18
B
Top Financial Stocks
See All »
B
B
JPM NYSE $291.66
B
V NYSE $305.53
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.50
Top Health Care Stocks
See All »
B
LLY NYSE $897.00
B
JNJ NYSE $239.24
B
AMGN NASDAQ $353.16
Top Real Estate Stocks
See All »
B
PLD NYSE $129.74